Stratification of Patients in Oncogeriatrics and Personalization of Interventions
ONKO-FRAIL
1 other identifier
interventional
186
1 country
3
Brief Summary
Multicenter randomized controlled trial. Patients will be randomly assigned to the control group or the intervention group in each of the health centers. The control group will receive the usual care, while the intervention group will add an individualized physical exercise program to the usual care. Cancer is a disease of the elderly. More than 65% of all malignancies affect this population. At the same time, the incidence of cancer cases increases and the need to better understand the biological characteristics of the disease, as well as those of the elderly who suffer from it, is highlighted. Oncogeriatrics is the area that addresses the care of the elderly patient with cancer, taking into account that physiological aging causes older people to have their own characteristics that require a differential approach in care. The low inclusion in clinical trials of elderly patients and the few specific trials carried out in this subpopulation together with the progressive aging of the population mean that the development of this area has become a priority in health policies. Therefore, there is a need to focus the research area on supervised physical exercise in older people with cancer in an innovative way, with the aim of generating new hypotheses that overcome existing limitations and facilitate the introduction into the health system of this type of interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2021
CompletedFirst Posted
Study publicly available on registry
November 23, 2021
CompletedStudy Start
First participant enrolled
January 27, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2024
CompletedAugust 20, 2024
June 1, 2023
1.9 years
July 29, 2021
August 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Short Physical Performance Battery
Short Physical Performance Battery (SPPB) evaluates balance, gait ability, and leg strength using a single tool. The score for each part is given in categorical modality (0-4). The best score will be 12 points. 1 point of change in the total score has demostrated to be of clinical relevance.
12 weeks
Secondary Outcomes (47)
Integral Geriatric Assessment -Socio-familial situation:
12 weeks
Integral Geriatric Assessment - Basic Activities of Daily Living ( BADL):
12 weeks
Integral Geriatric Assessment -Instrumental Activities of Daily Living (IADL):
12 weeks
Integral Geriatric Assessment -Cognitive function:
12 weeks
Integral Geriatric Assessment - Depression:
12 weeks
- +42 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONThe control group will receive the usual care and hygiene recommendations of the movement
Interventionist group
EXPERIMENTALThe interventional group will add an individualized physical exercise program to the usual care.
Interventions
Eligibility Criteria
You may qualify if:
- Patients aged 70 or over.
- Solid cancer.
- Candidates for systemic treatment (chemotherapy, hormone therapy, biological therapies or immunotherapy) if the time that has elapsed since the last dose of treatment has been at least 1 month (washout period).
- Patients with breast, gynecological, lung, pleural, digestive, urological, ENT area, sarcomas, brain tumors, melanomas and patients with tumors of unknown origin will be included.Regarding tumor type and stage for patients with lymphoma: 1) Diffuse large B-cell NHL: include stages I-II if Bulky (\>7.5 cm) or R-IPI\>1. 2) Hodgkin lymphoma: stages I-II if Bulky (\>10 cm). 3) Follicular NHL and marginal NHL without GELF treatment criteria. 4) 80 years old receiving 6 R-mini CHOP cycles.
You may not qualify if:
- ECOG ≥3
- cases of advanced dementia
- serious psychiatric illnesses
- Lack of basic fluency in the Basque or Spanish language
- those patients unable to get up from the chair and walk independently with or without auxiliary device.
- Neither will those patients who participate in other studies in which they are undertaking a physical exercise program be included.
- Absolute or relative contraindications in which the risk of adverse effects outweighs the possible benefits such as unstable angina, acute symptomatic heart failure ...
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hospital Universitario Donostia
San Sebastián, Guipuzcoa, 20014, Spain
Hospital Universitario Basurto
Bilbao, 48013, Spain
Hospital Universitario de Araba
Vitoria-Gasteiz, Álava, 01009, Spain
Related Publications (1)
Garcia-Garcia J, Rodriguez-Larrad A, de Rituerto Zeberio MM, Mediavilla JG, Vicente BL, Artola NT, Etxetxipia IZ, Garmendia I, Alberro A, Otaegui D, Rabasco FB, Caffarel MM, Vrotsou K, Irazusta J, Arrieta H, Pelaez M, Belloso J, Basterretxea L. Effects of a 12-week multicomponent exercise programme on physical function in older adults with cancer: Study protocol for the ONKO-FRAIL randomised controlled trial. J Geriatr Oncol. 2025 Dec 5;17(2):102818. doi: 10.1016/j.jgo.2025.102818. Online ahead of print.
PMID: 41352214DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2021
First Posted
November 23, 2021
Study Start
January 27, 2022
Primary Completion
January 1, 2024
Study Completion
May 3, 2024
Last Updated
August 20, 2024
Record last verified: 2023-06